Dielectric studies on struvite urinary crystals, a gateway to the new treatment modality for urolithiasis.

Spectrochim Acta A Mol Biomol Spectrosc

Division of Crystal Growth and Crystallography, School of Advanced Sciences, VIT University, Vellore 14, Tamil Nadu, India.

Published: September 2015

Struvite or magnesium ammonium phosphate hexahydrate (MAPH) are biological crystals, found in the kidney, which are formed due to the infection caused by urea splitting bacteria in the urinary tract. The struvite crystals observe different morphologies and were developed using single diffusion gel growth technique. The crystalline nature and its composition were studied from different characterization techniques like X-ray Diffraction (XRD) and FTIR. The dielectric behavior of the developed crystal was studied by varying temperature and at different frequencies. The parameters like dielectric constant, dielectric loss, ac conductivity, ac resistivity, impedance and admittance of the struvite crystals were calculated. The studies proved that the dielectric loss or dissipation heat is high in lower frequencies at normal body temperature, which develops a plasma state in the stones and in turn leads to the disintegration of urinary stones. The dielectric nature of the stones leads to the dielectric therapy, which will be a gateway for future treatment modality for urolithiasis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.saa.2015.03.136DOI Listing

Publication Analysis

Top Keywords

treatment modality
8
modality urolithiasis
8
struvite crystals
8
dielectric loss
8
dielectric
7
dielectric studies
4
struvite
4
studies struvite
4
struvite urinary
4
crystals
4

Similar Publications

Objective: Gestational diabetes mellitus (GDM) is a common medical complication of pregnancy that leads to adverse outcomes for both infants and pregnant people. Early detection and treatment can mitigate these negative outcomes. The COVID-19 pandemic strained healthcare and laboratory services, including GDM screening programs.

View Article and Find Full Text PDF

Inherited metabolic epilepsies-established diseases, new approaches.

Epilepsia Open

December 2024

Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity. These characteristics make it particularly challenging to establish their targeted therapies, and many of the IMEs are treated nowadays only symptomatically and supportively.

View Article and Find Full Text PDF

Background: Drop height has previously been used as an effective programming parameter in plyometric jump training. Less is known about the usage of maximal rebound jump height from a distinct drop height as a parameter for individualized plyometric jump training. Hence, the aim of this study was to contrast the effects of two different drop jump (DJ) training modalities using either the individualized maximal rebound height (MRHT) or a standard (SDHT) drop height on selected measures of physical fitness in young volleyball players.

View Article and Find Full Text PDF

Addition of Bevacizumab to Chemotherapy and Its Impact on Clinical Efficacy in Cervical Cancer: A Systematic Review and Meta-Analysis.

Pharmacy (Basel)

December 2024

Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town 11800, Penang, Malaysia.

: Cervical cancer is the third leading cause of cancer-related mortality in females. One of the most successful therapeutic modalities to date is suppressing vascular endothelial growth factor (VEGF)-mediated angiogenesis. Bevacizumab is a monoclonal antibody that targets VEGF-A.

View Article and Find Full Text PDF

The purpose of this review is to compile and discuss available evidence in humans on the efficacy of YHM supplementation on performance in different exercise modalities. Yohimbine (YHM) is a naturally occurring alkaloid that induces increases in sympathetic nervous system (SNS) activation effectively initiating "fight or flight" responses. In supplement form, YHM is commonly sold as an isolated product or combined into multi-ingredient exercise supplements and is widely consumed in fitness settings despite the lack of empirical support until recently.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!